Amgad M Rabie

19PUBLICATIONS
15CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designAllergyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 16, 2026
Potent halt of SARS-CoV-2 replication using clitocine-induced emergent-viral-RNA editing and disruption.

|Apr 21, 2025
Retraction of "Promising Experimental Anti-SARS-CoV-2 Agent "SLL-0197800": The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus".

Amgad M Rabie, Marwa A Abdel-Dayem, Mohnad Abdalla

|Jun 26, 2024
Revolutionizing Playing with Skeleton Atoms: Molecular Editing Surgery in Medicinal Chemistry.

Amgad M Rabie

|Dec 21, 2023
Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies.

Yasser Hussein Issa Mohammed, Israa M Shamkh, Nahed S Alharthi

|Dec 13, 2023
RNA: The most attractive target in recent viral diseases.

Amgad M Rabie

|Oct 09, 2023
Promising Experimental Anti-SARS-CoV-2 Agent "SLL-0197800": The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus.

Amgad M Rabie, Marwa A Abdel-Dayem, Mohnad Abdalla

Pageof 4

Frequent Collaborators

6 joint publications

Mohnad Abdalla

1 joint publications

Wafa A Eltayb

1 joint publications

Nermin A Osman

1 joint publications

Mohammed Moustapha Anwar